15,000
Participants
Start Date
Not specified
Study Completion Date
November 30, 2005
Influenza virus vaccine (CAIV-T)
Pedro A. Piedra, M.D., Houston
Collaborators (1)
Aviron LLC
INDUSTRY
National Institute of Allergy and Infectious Diseases (NIAID)
NIH